Carriers of GSTM1-null genotypes in European and Asian populations have been found to show significant risk of developing epilepsy, emphasizing the involvement of the antioxidant system in seizure susceptibility (Ercegovac et al., 2015; Prabha et al., 2016). This evidence concerns the gene GSTM1 and epilepsy.